Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers ...
Feb 27, 2024
0
3
The currently recommended five-day course of molnupiravir, an antiviral treatment, may not be long enough to treat COVID-19, according to a new paper involving UCL researchers.
Feb 27, 2024
0
28
Follwoing a a suspected bat bite Caroline Ford, worried she may have been exposed to rabies, sought treatment from AdventHealth Altamonte Springs. She called her insurance company, Anthem Blue Cross, and expected she'd need ...
Feb 20, 2024
0
1
For nearly a year, we have been debating weight loss drugs like Wegovy, Zepbound, Saxenda and similar products and what happens when people stop taking them. Are they able to maintain weight loss? A new Danish study sheds ...
Feb 20, 2024
0
29
Academic researchers from King's College London have investigated the early effects of an immunosuppressant drug that could help clinicians with future personalized approaches for the treatment of psoriasis.
Feb 19, 2024
0
19
A four-drug chemotherapy regimen of irinotecan liposome (Onivyde) in combination with oxaliplatin, leucovorin, and fluorouracil—together referred to as NALIRIFOX—has been approved by the U.S. Food and Drug Administration ...
Feb 16, 2024
0
4
New research by the University of Sussex could help to increase life expectancy and improve treatment for an aggressive brain cancer, which impacts thousands of people every year in the UK, and hundreds of thousands worldwide.
Feb 15, 2024
0
51
It was a last-ditch effort. For years doctors had tried to keep a patient's recurrent drug-resistant bacterial blood infection at bay, but it kept coming back and antibiotics were no longer working.
Feb 14, 2024
0
13
More than 26,000 people in the U.S. will be diagnosed with stomach cancer this year, and nearly 11,000 people will die of the disease, according to the American Cancer Society. Stomach cancer accounts for about 1.5% of all ...
Feb 7, 2024
0
0
Patient-reported outcomes are important indicators of how cancer drugs impact patients' lives. By assessing the benefits and risks of drugs from a patient's perspective, scientists and physicians can improve the development ...
Feb 6, 2024
0
0
